当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析 - 现金流量表

贝达药业

(300558)

  

流通市值:170.79亿  总市值:171.24亿
流通股本:4.17亿   总股本:4.18亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金2,043,623,012.91,286,443,980.67630,552,869.612,268,941,026.74
收到的税费返还---27,574,678.55
收到其他与经营活动有关的现金95,951,459.9181,476,251.0744,728,944.64103,878,367.53
经营活动现金流入的平衡项目0000
经营活动现金流入小计2,139,574,472.811,367,920,231.74675,281,814.252,400,394,072.82
购买商品、接受劳务支付的现金135,644,689.0585,325,548.0737,482,208.39266,889,742.17
支付给职工以及为职工支付的现金431,619,614.07306,676,511.05199,114,465.21534,087,293.24
支付的各项税费72,585,574.6641,548,884.815,855,962.13139,073,800.89
支付其他与经营活动有关的现金939,736,495.49574,008,473.57284,804,725.221,153,603,602.69
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,579,586,373.271,007,559,417.49537,257,360.952,093,654,438.99
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额559,988,099.54360,360,814.25138,024,453.3306,739,633.83
二、投资活动产生的现金流量:
收回投资收到的现金---251,511,335.2
处置固定资产、无形资产和其他长期资产收回的现金净额22,476,71522,620,698.4621,512,338.78685,767.53
投资活动现金流入的平衡项目0000
投资活动现金流入小计22,476,71522,620,698.4621,512,338.78252,197,102.73
购建固定资产、无形资产和其他长期资产支付的现金829,182,730.32646,722,780.64306,072,268.981,010,539,446.15
投资支付的现金431,430,041.64264,750,000249,750,000565,999,999.8
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,260,612,771.96911,472,780.64555,822,268.981,576,539,445.95
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-1,238,136,056.96-888,852,082.18-534,309,930.2-1,324,342,343.22
三、筹资活动产生的现金流量:
吸收投资收到的现金60,788,152.1918,995,335.3918,995,335.3953,782,504.8
取得借款收到的现金1,740,000,0001,538,000,0001,120,000,0001,036,030,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,800,788,152.191,556,995,335.391,138,995,335.391,089,812,504.8
偿还债务支付的现金380,010,000330,000,000157,000,000-
分配股利、利润或偿付利息支付的现金69,038,144.1956,886,107.3321,675,813.67139,518,941.61
支付其他与筹资活动有关的现金716,490,862.42716,490,862.42709,566,862.428,773,630.87
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,165,539,006.611,103,376,969.75888,242,676.09148,292,572.48
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额635,249,145.58453,618,365.64250,752,659.3941,519,932.32
四、汇率变动对现金及现金等价物的影响5,924,487.526,697,144.46-779,948.7915,378,082.61
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-36,974,324.32-68,175,757.83-146,312,766.39-60,704,694.46
加:期初现金及现金等价物余额731,284,859.68731,284,859.68731,284,859.68791,989,554.14
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额694,310,535.36663,109,101.85584,972,093.29731,284,859.68
补充资料:
净利润-141,577,333.72-124,763,291.36
资产减值准备-2,432,445.47-6,017,040.93
固定资产和投资性房地产折旧-45,176,840.39-96,274,106.8
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-45,176,840.39-96,274,106.8
无形资产摊销-93,805,357.35-150,346,775.13
处置固定资产、无形资产和其他长期资产的损失-339,646.19--88,610,447.72
固定资产报废损失----515,307.62
公允价值变动损失---1,005,506.85
财务费用-22,403,766.49-186,253,313.9
投资损失-10,382,093.83-19,612,809.97
递延所得税-1,330,078.18--41,767,807.53
其中:递延所得税资产减少-3,623,096.08--42,630,444.4
递延所得税负债增加--2,293,017.9-862,636.87
存货的减少-12,222,271.31--78,850,967.56
经营性应收项目的减少--90,162,626.29--198,293,802.41
经营性应付项目的增加-78,701,683.38--9,103,795.08
其他-40,293,924.11-132,528,345.11
现金的期末余额-663,109,101.85-731,284,859.68
减:现金的期初余额-731,284,859.68-791,989,554.14
公告日期2023-10-252023-08-262023-04-282023-04-24
审计意见(境内)标准无保留意见
TOP↑